Gregory L. Verdine - 05 Mar 2025 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role: Director
Signature: /s/ Gregory L. Verdine
Issuer symbol: WVE
Transactions as of: 05 Mar 2025
Net transactions value: +$660,677
Form type: 4
Filing time: 07 Mar 2025, 21:00:05 UTC
Previous filing: 14 Aug 2024
Next filing: 13 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WVE	Ordinary Shares	Options Exercise	$329,840	+133,000	+288%	$2.48	179,155	05 Mar 2025	Direct
transaction	WVE	Ordinary Shares	Options Exercise	$330,837	+133,402	+74%	$2.48	312,517	07 Mar 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WVE	Share Option (right to buy)	Options Exercise	$0	-133,000	-50%	$0.000000	133,402	05 Mar 2025	Ordinary Shares	133,000	$2.48	Direct	F1
transaction	WVE	Share Option (right to buy)	Options Exercise	$0	-133,402	-100%	$0.000000	0	07 Mar 2025	Ordinary Shares	133,402	$2.48	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The share options that were exercised via cash purchase in this reportable transaction were fully vested.